Lu Chen
Impact in
- Oncology top 2%
- Lymphatic System and Diseases
- Global Cancer Incidence and Screening
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in ⓘ
-
- RNA modifications and cancer 13
- Circular RNAs in diseases 7
- Oncology 37
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Claus Cursiefen (1 shared paper)J. Wayne Streilein (1 shared paper)Stanley J. Wiegand (1 shared paper)Jingtai Cao (1 shared paper)M. Reza Dana (1 shared paper)Patrìcia A. D'Amore (1 shared paper)David G. Jackson (1 shared paper)Czeslaw Radziejewski (1 shared paper)
- Journals
- Blood (6 papers)Journal of Clinical Oncology (3 papers)Journal of Neuroscience (3 papers)Frontiers in Cell and Developmental Biology (2 papers)European Journal of Pharmacology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lu Chen
128 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 1.0k
- Cancer Research 507
- Immunology 443
- Pathology and Forensic Medicine 345
- Molecular Biology 1.2k
Countries citing papers authored by Lu Chen
This map shows the geographic impact of Lu Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Chen more than expected).
Fields of papers citing papers by Lu Chen
This network shows the impact of papers produced by Lu Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Chen. The network helps show where Lu Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 140 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment Hit paper breakdown → | 2004 | 866 |
| 2 | 2015 | 120 | |
| 3 | 2021 | 111 | |
| 4 | 2010 | 92 | |
| 5 | 2006 | 88 | |
| 6 | 2020 | 83 | |
| 7 | 2017 | 70 | |
| 8 | 2013 | 65 | |
| 9 | 2015 | 65 | |
| 10 | 2014 | 64 | |
| 11 | 2014 | 64 | |
| 12 | 2016 | 63 | |
| 13 | 2013 | 62 | |
| 14 | 2016 | 60 | |
| 15 | 2021 | 50 | |
| 16 | 2023 | 50 | |
| 17 | 2005 | 45 | |
| 18 | 2013 | 45 | |
| 19 | 2014 | 43 | |
| 20 | 2020 | 42 |
About Lu Chen
Lu Chen is a scholar working on Molecular Biology, Oncology, Cancer Research, Pathology and Forensic Medicine and Surgery, having authored 140 papers that have together received 3.4k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (14 papers), Cancer-related molecular mechanisms research (14 papers), RNA modifications and cancer (13 papers), Circular RNAs in diseases (7 papers), CAR-T cell therapy research (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers) and Neuroscience of respiration and sleep (6 papers). The work is most often cited by research in Oncology (1.0k citations), Cancer Research (507 citations), Immunology (443 citations), Pathology and Forensic Medicine (345 citations) and Molecular Biology (1.2k citations). Lu Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Claus Cursiefen, J. Wayne Streilein, Stanley J. Wiegand, Jingtai Cao, M. Reza Dana, Patrìcia A. D'Amore, David G. Jackson, Czeslaw Radziejewski, Christopher I. Li and Xiang Yang Chen. Their work appears in journals such as Blood, Journal of Clinical Oncology, Journal of Neuroscience, Frontiers in Cell and Developmental Biology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.